Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.